Device Trial Radar · NCT07946237
Optimizing Cough Rehabilitation Through Combined Cough Skill Training and Transcutaneous Spinal Cord Stimulation
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
16
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Sep 30, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- University of FloridaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- American Speech-Language-Hearing Foundation
- First posted
- Nov 18, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate the effects of combining cough training with low-level electrical stimulation to the neck (tsDCS) in healthy adults and adults with neurological diseases. The main questions it aims to answer are: * Is using tsDCS during cough training safe, tolerable, and acceptable to participants? * What tsDCS settings are most effective for pairing with cough training? Researchers will compare sham stimulation with active tsDCS to see if tsDCS enhances cough gains. Before and after each testing session, participants will complete breathing, coughing, and respiratory-strength training.
Conditions
- Healthy Adult
- Rehabilitation Exercise
- Electric Stimulation Therapy
- Cough Peak Flow
- Ventilatory Function
Interventions
transcutaneous spinal direct current stimulationDevice
Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes.
Cough Skill TrainingBehavioral
CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak).
Sham stimulationDevice
Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Completion of training tasks with simultaneous stimulationTime frame: During training
- Peak Cough FlowTime frame: Baseline, immediate post-single-treatment measurement
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Florida
Gainesville, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.